• 1

    Japan Ranks 9th Among 10 in AI Analysis of EFPIA Pharma Strategy Report

  • 2

    Pfizer Hails Adult Rollout of Prevenar 20 as “Milestone” for Public Health

  • 3

    Japan Hands Out Orphan Tags to Ianalumab, Bleximenib, and Lots More Drugs

  • 4

    Japan Ophthalmology Society Flags Off-Label Concerns Ahead of Upneeq Launch

  • 5

    MHLW Says Trial Recruitment Info Not Deemed Advertising Under PMD Act